Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

被引：0
|
作者：
Axel Heidenreich
Silke Gillessen
Daniel Heinrich
Daniel Keizman
Joe M. O’Sullivan
Joan Carles
Manfred Wirth
Kurt Miller
John Reeves
Monica Seger
Sten Nilsson
Fred Saad
机构：
[1] University Hospital Cologne,Department of Urology
[2] Division of Cancer Sciences,Department of Oncology
[3] University of Manchester and the Christie,Department of Medical Oncology
[4] Medical Oncology and Haematology,Department of Urology
[5] Kantonsspital St Gallen,Department of Urology
[6] University of Bern,Department of Oncology
[7] Akershus University Hospital,Department of Urology
[8] Genitourinary Oncology Service,undefined
[9] Institute of Oncology,undefined
[10] Meir Medical Center,undefined
[11] Department of Clinical Oncology,undefined
[12] The Centre for Cancer Research and Cell Biology,undefined
[13] Queen’s University Belfast and the Northern Ireland Cancer Centre,undefined
[14] Vall d’Hebron University Hospital,undefined
[15] Vall d’Hebron Institute of Oncology,undefined
[16] University Hospital Carl-Gustav Carus,undefined
[17] Charité University Medicine Berlin,undefined
[18] Pharmaceutical Division of Bayer,undefined
[19] Karolinska University Hospital,undefined
[20] Centre Hospitalier de l’Université de Montréal (CHUM),undefined
来源：
BMC Cancer | / 19卷
关键词：
Radium-223; mCRPC, asymptomatic; Symptomatic; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [22] The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
    Ram, Prasanna
    Mandal, Swarnendu
    Das, Manoj K.
    Nayak, Prasant
    PROSTATE, 2023, 83 (06): : 613 - 613
  • [23] The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
    Liu, Alex J.
    Kosiorek, Heidi E.
    Ueberroth, Benjamin E.
    Jaeger, Ellen
    Ledet, Elisa
    Kendi, Ayse T.
    Tzou, Katherine
    Quevedo, Fernando
    Choo, Richard
    Moore, Cassandra N.
    Ho, Thai H.
    Singh, Parminder
    Keole, Sameer R.
    Wong, William W.
    Sartor, Oliver
    Bryce, Alan H.
    PROSTATE, 2022, 82 (12): : 1202 - 1209
  • [24] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
    Curley, Tracy
    Arauz, Gabrielle
    Jensen, Trine
    Wahba, Mona
    Delacruz, Anthony
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
  • [25] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [26] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [27] Clinical experience of using the radium-223 in patients with bone metastasis of castration-resistant prostate cancer
    Yurmazov, Z. A.
    Usynin, E. A.
    Medvedeva, A. A.
    Polyakov, A. A.
    Lushnikova, N. A.
    Chernov, V., I
    Spirina, L., V
    ONKOUROLOGIYA, 2022, 18 (01): : 70 - 76
  • [28] Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients
    Wirth, M.
    Saad, F.
    Gakeran, J. C.
    Gillessen, S.
    Heinrich, D.
    Graft, J.
    Miller, K.
    Nilsson, S.
    Sullivan, O. J.
    Tucci, M.
    Heidenreich, A.
    Oncology Research and Treatment, 2015, 38 : 266 - 266
  • [29] EFFICACY AND SAFETY ANALYSIS OF RADIUM-223 IN PATIENTS WITH PROSTATE CANCER CASTRATION-RESISTANT AND BONE METASTASIS
    Alvis-Guzman, N.
    Huerfano, L. M.
    Alvis-Zakzuk, N. J.
    Romero Prada, M. E.
    Alvis-Guzman, N.
    Huerfano, L. M.
    VALUE IN HEALTH, 2018, 21 : S16 - S17
  • [30] Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
    Takalkar, Amol
    Paryani, Bhavna
    Skweres, Justin
    Adams, Scott
    Devarakonda, Srinivas
    Dhawan, Manish
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345